Emerg Infect Dis. 2022 Oct;28(10):2130-2132. doi: 10.3201/eid2810.220691. Epub 2022 Sep 1.
In a cohort of persons living with HIV in Hong Kong, surrogate virus neutralization testing for COVID-19 yielded a median level of 89% after the third dose of an inactivated COVID-19 vaccine, compared with 37% after the second dose. These results support using a 3-dose primary series for enhanced immune protection.
在香港的一组 HIV 感染者中,与第二剂相比,第三剂灭活 COVID-19 疫苗后,用于 COVID-19 的替代病毒中和检测产生的中位数水平为 89%,而第二剂后为 37%。这些结果支持使用三剂初级系列来增强免疫保护。